Eine Gruppe von Antibiotika antibiotika-wiki.de , zu denen das Natürliche Antibiotikum Lincomycin und sein halbsynthetisches Analogon Clindamycin gehören. Sie haben bakteriostatische oder bakterizide Eigenschaften, abhängig von der Konzentration im Körper und der Empfindlichkeit von Mikroorganismen. Die Wirkung ist auf die Unterdrückung der Proteinsynthese in Bakterienzellen durch Bindung DER 30s-Subeinheit der ribosomalen Membran zurückzuführen. Lincosamide sind resistent gegen die Wirkung von Salzsäure Magensaft. Nach oraler Verabreichung wird schnell absorbiert. Es wird für Infektionen verwendet, die durch Gram-positive Kokken (hauptsächlich als Medikamente der zweiten Reihe) und unvorhersehbare anaerobe Flora verursacht werden.
Cuando se vincula un sitio web que vende productos farmacéuticos desde otro sitio - comprar-farmacia.es, como Search Engine Marketing a través del programa AdSense de Google, la degradación resultante puede disminuir drásticamente la cantidad de ingresos publicitarios obtenidos por el sitio web. Lo mismo se aplica a cualquier inclusión pagada. Esencialmente, el servidor de anuncios sirve una página desde su propio dominio. Si la página contiene un banner (es decir, una imagen) del dominio de una marca, la marca recibirá una parte de los ingresos publicitarios.
Versuchen Sie, bei uns zu bestellen und Sie werden nicht enttäuscht sein, beste Auswahl in der ganzen Schweiz, ausgezeichnete Produktqualität, sehr schnelle Lieferung und echte Privatsphäre!
Test
Ark Pharm, Inc. MATERIAL SAFETY DATA SHEET 1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION MSDS Name: Tretinoin CAS Number: 302-79-4 Catalog Numbers: AK-73126 Company Identification: 2. COMPOSITION, INFORMATION ON INGREDIENTS Molecular Formula: Molecular Weight: Component Concentration CAS Number 3. HAZARDS IDENTIFICATIONEMERGENCY OVERVIEW 3.1 Classification of the substance or mixture Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP]
Specific target organ toxicity - single exposure (Category 3)
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Harmful if swallowed. Irritating to eyes, respiratory system and skin.
3.2 Label elements Labelling according Regulation (EC) No 1272/2008 [CLP]
IF IN EYES: Rinse cautiously with water for several
minutes. Remove contact lenses, if present and easy to do. Ark Pharm, Inc. According to European Directive 67/548/EEC as amended
Irritating to eyes, respiratory system and skin.
immediately with plenty of water and seek medical advice.
Wear suitable protective clothing and gloves. 3.3 Other hazards 4. FIRST AID MEASURES Eyes: Flush eyes with plenty of water occasionally lifting the upper and lower lids. Get medical aid. Skin: Get medical aid. Flush skin with plenty of water while removing contaminated clothing and shoes. Ingestion: Get medical aid. Wash mouth out with water. Inhalation: Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is 5. FIRE FIGHTING MEASURES General Information: As in any fire, wear a self-contained breathing apparatus and full protective gear. Extinguishing Media: Use water spray, dry chemical, carbon dioxide or chemical foam. 6. ACCIDENTAL RELEASE MEASURES General Information: Use proper personal protective equipment. Spills/Leaks: Vacuum or sweep up material and place into suitable disposalcontainer. Avoid generating dusty conditions. 7. HANDLING AND STORAGE Handling: Avoid breathing dust, vapor, mist or gas. Avoid contact with eyes, skin. Storage: Storage temperature: 2 - 4 °C and Keep container tightly closed in a dry and well-ventilated place. 8. EXPOSURE CONTROLS, PERSONAL PROTECTION Engineering Controls: Facilities storing or utilizing this material should be equipped with an eyewash facility and safety
shower. Use adequate ventilation to keep airborne concentrations low.
Personal Protective Equipment Eyes: Wear chemical safety goggles. Skin: Wear appropriate protective gloves to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure. Respirators: Wear appropriate respirators where necessary. 9. PHYSICAL AND CHEMICAL PROPERTIES Ark Pharm, Inc. 10. STABILITY AND REACTIVITY Chemical Stability: This product is relatively unstable under normal temperature. Incompatibilities with Other Materials: Strong oxidizing agents. Hazardous combustion or Decomposition products: Carbon monoxide, carbon dioxide. 11. TOXICOLOGICAL INFORMATION 11.1 Information on toxicological effects Acute toxicity Skin corrosion/irritation Serious eye damage/eye irritation Respiratory or skin sensitization Germ cell mutagenicity Carcinogenicity
No component of this product present at levels greater than or equal to 0.1% is identified as probable,
possible or confirmed human carcinogen by IARC. Reproductive toxicity Specific target organ toxicity - single exposure Specific target organ toxicity - repeated exposure Aspiration hazard Additional Information
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.
12. ECOLOGICAL INFORMATION 12.1 Toxicity 12.2 Persistence and degradability 12.3 Bioaccumulative potential 12.4 Mobility in soil 12.5 Results of PBT and vPvB assessment 12.6 Other adverse effects Ark Pharm, Inc. 13. DISPOSAL CONSIDERATIONS 13.1 Waste treatment methods
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed professional waste disposal
service to dispose of this material. Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator
equipped with an afterburner and scrubber.
Contaminated packaging 14. TRANSPORT INFORMATION 14.1 UN number 14.2 UN proper shipping name 14.3 Transport hazard class(es) 14.4 Packaging group 14.5 Environmental hazards 14.6 Special precautions for user 15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006. Safety, health and environmental regulations/legislation specific for the substance or mixture: Chemical Safety Assessment: No data available. 16. ADDITIONAL INFORMATION
The above information pertains to this product as currently formulated, and is based on the information available at this time.
Addition of reducers or other additives to this product may substantially alter the composition and hazards of the product. Since
conditions of use are outside our control, we make no warranties, express or implied, and assume no liability in connection
RENEWAL MINISTRIES REPORT ON HAITI 2009 Renewal Ministries was invited by Haiti Missions to add a “spiritual dimension” to their humanitarian work in Haiti—a kind of melting together of proclamation and demonstration of the Gospel. We flew from Texas to Miami and met the team who were mainly from Louisiana. We were here with a pharmacist, Deacon Lloyd Duplantis and his wife Faie who are
Lilly controls my Foriginals Domenico Quaranta Critical text written for the exhibition UBERMORGEN.COM: ART FID [F]originals – Authentizität als konsensuelle Halluzination (May 27 – July 16, 2006, Curated by Inke Arns, Hartware MedienKunstVerein – PHOENIX Halle, Dortmund This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.